Informed consent during the clinical emergency of acute myocardial infarction (HER0-2 consent substudy): a prospective observational study

This publication has 14 references indexed in Scilit:

• Thrombin-specific anticoagulation with bivalirudin versus heparin in patients receiving fibrinolytic therapy for acute myocardial infarction: the HERO-2 randomised trial
  The Lancet, 2001
• Patients' experiences of intervention trials on the treatment of myocardial infarction: is it time to adjust the informed consent procedure to the patient's capacity?
  Heart, 2001
• Is informed consent to clinical trials an “upside selective” process in acute coronary syndromes?
  American Heart Journal, 2000
• The impact of disease severity on the informed consent process in clinical research
  The American Journal of Medicine, 1996
• Are we promoting true informed consent in cardiovascular clinical trials?
  Journal of Cardiovascular Nursing, 1995
• Informed consent in European multicentre randomised clinical trials — Are patients really informed?
  European Journal Of Cancer, 1994
• Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients
  Published by Elsevier ,1994
• An International Randomized Trial Comparing Four Thrombolytic Strategies for Acute Myocardial Infarction
  New England Journal of Medicine, 1993
• Defining Patient Competence for Medical Decision Making
  Chest, 1991
• Very early thrombolytic therapy in suspected acute myocardial infarction
  The American Journal of Cardiology, 1990